NHI-2
NHI-2 is a small molecule which can act as a LDHA inhibitor. It is provided as a powder.
This product acts on the following target types: Dehydrogenase (GAPDH, GPDH, IMPDH, PHGDH, LDH, DHODH, ALDH, GDH, IDH, UGDH, DPD, DHPDH, and MDH).
This product acts on the following biochemical pathways: NAD biosynthesis, Warburg effect.
This product may be of interest in the following research areas and diseases: Oxidative stress, Cancer.
Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
This product acts on the following target types: Dehydrogenase (GAPDH, GPDH, IMPDH, PHGDH, LDH, DHODH, ALDH, GDH, IDH, UGDH, DPD, DHPDH, and MDH).
This product acts on the following biochemical pathways: NAD biosynthesis, Warburg effect.
This product may be of interest in the following research areas and diseases: Oxidative stress, Cancer.
Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx283047-50MG |
| Pricing | 50 mg USD $580.0 |
| Availability | Shipped within 5-10 working days. |
| Dry Ice | No |
| Note |
|
| CAS Number | 1269802-97-2 |